What: A recent ruling by a federal judge halted the Trump administration’s attempt to freeze billions in federal funds, including Medicaid payments vital to maternal care.
Key line: [Details not provided].
Source: Washington Post.
The New York Times reports that a freeze on US foreign aid has decimated women’s health care globally, affecting millions seeking maternity care and other services.
ProPublica’s review of Texas hospital data reveals a more than 50% increase in sepsis rates among pregnant women after abortion was banned.
A study reveals that from 2001 to 2020, early-onset breast cancer rates among women ages 25–39 varied significantly by region in the United States.
The Trump administration’s removal of CDC pages is disrupting detailed contraceptive guidelines.
A marijuana business trade publication reports that some producers are eyeing cannabis-based treatments for women’s health issues.
An Associated Press overview details how various states are introducing bills to criminalize women for obtaining abortion pills.
Oregon lawmaker Shelly Boshart Davis recounts her personal experience of being denied menopause care and advocates for insurer coverage of hormone therapy.
A California study found that over 60% of pregnancy-related hemorrhage deaths were preventable due to delays in response and inadequate management.
An analysis of emerging investment trends shaping the future of women’s health research.
A University of Michigan study finds that women are 60% more likely than men to develop infections following heart surgery.
A systematic review suggests acupuncture may help manage menopausal insomnia—with few side effects, though the evidence is rated low to moderate.
A nonprofit representing thousands of physicians is suing to restore access to public health data.
A study from the University of Washington finds significant racial and socioeconomic disparities in accessing same-day diagnostic services after an abnormal mammogram.
The abrupt cancellation of NIH meetings may hinder critical medical research.
Beyond recreation, cannabis is being evaluated for therapeutic benefits in women’s care.
A randomized control trial found that postpartum women treated with nifedipine had a dramatically lower readmission rate than those on labetalol.
An OBGYN in Texas describes how strict abortion bans are stripping patients of decision-making power in their healthcare.
Cannabis producers are exploring new treatment areas in women’s health.
KFF Health News reports a woman was billed over $14,000 for an IUD she thought was covered by insurance.
A report highlights confusion over Tennessee’s recent Medicaid expansion for postpartum care.